Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-30 Purchase | 2024-10-02 08:00 am | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 23,836 | $0.47442 | $11,308 | 214,349 (Indirect Direct) | View |
2024-05-28 Purchase(A) | 2024-07-31 4:09 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 15,000 | $0.5183 | $7,775 | 3,165,712 (Indirect Direct) | View |
2024-05-21 Purchase(A) | 2024-07-31 4:08 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 50,000 | $0.6095 | $30,475 | 3,150,712 (Indirect Direct) | View |
2024-05-10 Purchase(A) | 2024-07-31 4:07 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 40,000 | $0.47163 | $18,865 | 3,100,712 (Indirect Direct) | View |
2024-05-07 Purchase(A) | 2024-07-31 4:07 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 66,300 | $0.3743 | $24,816 | 3,060,712 (Indirect Direct) | View |
2024-05-06 Purchase(A) | 2024-07-31 4:06 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 135,000 | $0.3753 | $50,666 | 2,994,412 (Indirect Direct) | View |
2024-04-19 Purchase(A) | 2024-07-31 4:06 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 15,000 | $0.5199 | $7,799 | 2,859,412 (Indirect Direct) | View |
2024-04-17 Purchase(A) | 2024-07-31 4:05 pm | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 245,072 | $0.53622 | $131,411 | 2,844,412 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-28 Option Award | 2024-06-03 09:00 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 15,000 | $0.5183 | 3,165,712 (Direct) | View |
2024-05-21 Option Award | 2024-05-23 06:00 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 25,000 | $0.579 | 3,150,712 (Direct) | View |
2024-05-22 Option Award | 2024-05-23 06:00 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 25,000 | $0.64 | 3,150,712 (Direct) | View |
2024-05-10 Option Award | 2024-05-14 07:53 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 20,000 | $0.465 | 3,100,712 (Direct) | View |
2024-05-13 Option Award | 2024-05-14 07:53 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 10,000 | $0.49 | 3,100,712 (Direct) | View |
2024-05-11 Option Award | 2024-05-14 07:53 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 10,000 | $0.4665 | 3,100,712 (Direct) | View |
2024-05-07 Option Award | 2024-05-07 7:41 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 66,300 | $0.3743 | 3,060,712 (Direct) | View |
2024-05-06 Option Award | 2024-05-07 09:14 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 135,000 | $0.3753 | 2,994,412 (Direct) | View |
2024-04-19 Option Award | 2024-04-25 4:01 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 15,000 | $0.5199 | 2,859,412 (Direct) | View |
2024-04-18 Option Award | 2024-04-19 06:05 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 115,072 | $0.5255 | 2,844,412 (Direct) | View |
2024-04-17 Option Award | 2024-04-19 06:05 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 130,000 | $0.5457 | 2,844,412 (Direct) | View |
2024-03-11 Option Award | 2024-03-13 8:54 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 305,198 | $0 | 2,599,340 (Direct) | View |
2023-08-02 Option Award | 2023-08-04 4:05 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO | 31,185 | $0 | 2,294,142 (Direct) | View |
2023-04-20 Option Award | 2023-04-24 06:44 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & Co-CEO | 75,000 | $0 | 2,262,957 (Direct) | View |
2022-09-18 Option Award | 2023-01-04 07:35 am | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer | 31,185 | $0 | 2,187,957 (Direct) | View |
2021-12-10 Option Award | 2021-12-10 8:04 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer | 31,185 | $0 | 2,156,772 (Direct) | View |
2020-07-26 Option Award | 2020-07-31 5:10 pm | N/A N/A | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer | 31,185 | $0 | 2,125,587 (Direct) | View |